# Ground Truth Medical Form (GTMF)

## Patient Information

- **Subject ID**: 22844
- **Admission ID**: 148584
- **Row ID**: 16302
- **Profile Type**: FULL

## Demographics

- **Age**: 26
- **Sex**: M
- **Date of Birth**: 2143-07-02
- **Ethnicity**: WHITE
- **Marital Status**: SINGLE
- **Religion**: NOT SPECIFIED
- **Insurance**: Private
- **Admission Type**: EMERGENCY
- **Admission Date**: 2170-01-06 20:14:00
- **Discharge Date**: 2170-03-10 14:49:00

## Symptoms

- **fever** | duration: several days | severity: spiked to 102-103 daily
- **headache (increased with fever spikes)**
- **occasional left ear fullness**
- **erythematous raised lesion on scalp (appeared to be a bug bite)** | duration: resolved after one to two days

## Medical History

AML and ALL, status post treatment

## Current Medications

- **acyclovir**
- **Nystatin**

## Diagnoses

- **Fever, likely secondary to infection or active leukemia** | notes: No clear source identified; C. difficile toxin positive; possible sinusitis or mastoiditis on MRI
- **C. difficile infection** | notes: Positive C. difficile toxin
- **Possible sinusitis or mastoiditis (left side)** | notes: MRI showed question of sinusitis or mastoiditis
- **Bug bite (scalp)** | notes: Erythematous raised lesion, resolved in 1-2 days

## Treatment Options

### Empiric antibiotic therapy

**Details**: Started on Levaquin, then cefepime (dose increased), vancomycin added, AmBisome added

**Medications**:
- Levaquin (not provided)
- Cefepime (2 grams IV q.d., then increased to 2 grams IV t.i.d.)
- Vancomycin (1 gram IV)
- AmBisome (450 mg IV)

### Treatment for C. difficile

**Details**: Flagyl started after positive C. difficile toxin

**Medications**:
- Flagyl (500 mg p.o.)

### Chemotherapy

**Details**: High-dose Ara-C given for possible active leukemia

**Medications**:
- Ara-C (cytarabine) (high-dose)

### Supportive care

**Details**: Transfusions of packed red blood cells and platelets

### Empiric treatment for possible sinusitis/mastoiditis

**Details**: Empirically treated after MRI findings

### neutropenic precautions

**Details**: Patient was walking around on and off the floor under neutropenic precautions.
